Cardiovascular Digital Solutions Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | iRythm Technologies Inc., Apple Inc., General Electric Company, Uber Diagnostics Private Limited, AlivCor Inc., Verily Life Sciences, H

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2175

The Business Research Company offers in-depth market insights through Cardiovascular Digital Solutions Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cardiovascular digital solutions market size has grown rapidly in recent years. It will grow from $91.02 billion in 2023 to $100.81 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rise in cardiovascular diseases, telemedicine adoption, data analytics for risk prediction, patient engagement initiatives, remote patient monitoring..

The cardiovascular digital solutions market size is expected to see rapid growth in the next few years. It will grow to $147.86 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to artificial intelligence and machine learning integration, expanding role of digital biomarkers, remote cardiac rehabilitation programs, interoperability of healthcare systems, focus on real-time monitoring and alerts.. Major trends in the forecast period include blockchain for secure health data management, integration of ehrs and cardiovascular digital solutions, mobile health apps for cardiovascular management, focus on cardiovascular rehabilitation solutions, collaborations between tech companies and healthcare providers..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9613&type=smp

Market Segmentation:
The cardiovascular digital solutions market covered in this report is segmented -

1) By Components: Devices, Software
2) By Services: Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs, Other Services
3) By Deployment: Cloud-Based, On-Premise
4) By End-Use: Hospitals and Clinics, Ambulatory Care Centers, Other End-Users

Major Driver - Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solutions Market
The rise in cardiovascular disease prevalence worldwide is expected to propel the growth of the cardiovascular digital solutions market going forward. Heart and blood vessel problems are referred to as cardiovascular diseases (CVDs). It is a common phrase for diseases that damage the heart or blood vessels. Cardiovascular digital solutions aid in promoting patient autonomy by allowing patients to self-monitor health activities that decrease disease risk factors while encouraging adherence to these lifestyle changes. The use of these solutions decreased the morbidity and mortality of cardiovascular diseases. So, the surge in cases of cardiovascular diseases boosts the market for cardiovascular digital solutions. For instance, in 2022, according to a report shared by the World Heart Federation, a Switzerland-based non-profit organization of the global cardiovascular community, the projected number of deaths due to cardiovascular diseases is expected to increase, reaching over 22.2 million in 2030 and 32.3 million in 2050, up from an estimated 18.9 million in 2020. Therefore, the rise in cardiovascular disease prevalence worldwide is driving the cardiovascular digital solutions market

Competitive Landscape:
Major companies operating in the cardiovascular digital solutions market report are iRythm Technologies Inc., Apple Inc., General Electric Company, Uber Diagnostics Private Limited, AlivCor Inc., Verily Life Sciences, HeartFlow Inc., Bardy Diagnostics Inc., BioTelemetry Inc., eviCore healthcare, Nanowear Inc, Cardiac Insight Inc., Bay Labs Solutions, Change Healthcare, Medtronic PLC, BenevolentAI Limited, Cardiologs Technologies, Cardiopulmonary Corp., Congenica Ltd., Cyient Limited, Data4Cure Inc., Deep Genomics Incorporated, DNAnexus Inc., Emedgene Technologies Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings Inc., GNS Healthcare, IBM Watson Health, Illumina Inc., Microsoft Corporation, Niramai Health Analytix, NVIDIA Corporation, Omron Healthcare Co. Ltd. .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/cardiovascular-digital-solutions-global-market-report

Top Trend - Product Innovation In Cardiovascular Digital Solutions Market
Product innovation is the key trend gaining popularity in the cardiovascular digital solutions market. Major companies operating in the cardiovascular digital solutions market are focused on developing innovative products to strengthen their position in the market. For instance, in February 2023, Eko Health, a US-based manufacturer of digital health solutions for heart and lung disease, launched the SENSORA Cardiac Disease Detection Platform. SENSORA is a cardiovascular disease detection platform that blends the most recent advances in applied machine learning with one of the world's most used medical devices: the stethoscope. Eko has invented a detection platform that might grow as the business creates applications for other cardiac disorders by using its digital stethoscopes to record and analyze electrical signals and heart sounds. SENSORA primarily incorporates AI that reliably recognizes structural murmurs, which indicate heart valve disease, and Care Pathway Analytics software that offers downstream insight and analytics of the care process through the healthcare system.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cardiovascular Digital Solutions Market Characteristics
3. Cardiovascular Digital Solutions Market Trends And Strategies
4. Cardiovascular Digital Solutions Market - Macro Economic Scenario
5. Cardiovascular Digital Solutions Market Size And Growth
…..
27. Cardiovascular Digital Solutions Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.